MLTX - Financial Reports List - MoonLake Immunotherapeutics - IntrinsicAlpha

MoonLake Immunotherapeutics MLTX

Healthcare - Biotechnology - NASDAQ - CH

$ 39.45

4.37 %

$ 2.5 B

Market Cap

-21.16

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	416.01%	-513.20%	-229.90%
Annual Report	FY	10-K	2024-12-31	0.00%	-335054.64%	100.00%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-275.45%	-232.23%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-139.34%	-131.90%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-11.90%	-53.27%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-284.32%	9.99%
Annual Report	FY	10-K	2023-12-31	0.00%	44.18%	16.81%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	36.06%	12.14%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	41.78%	25.30%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	23.05%	18.89%

1